These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37338470)

  • 1. Impact of anemia on sputum smear conversion and treatment outcomes among newly diagnosed tuberculosis patients in Southern India.
    Hithaish Kumar RN; Rao CR; Maradi R; Umakanth S; Chidananda Sanju SV; Sreenivasa Rao BP
    Int J Mycobacteriol; 2023; 12(2):117-121. PubMed ID: 37338470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania.
    Nagu TJ; Spiegelman D; Hertzmark E; Aboud S; Makani J; Matee MI; Fawzi W; Mugusi F
    PLoS One; 2014; 9(3):e91229. PubMed ID: 24642636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevalence of Absolute and Functional Iron Deficiency Anemia in New Cases of Smear-positive Pulmonary Tuberculosis and Their Sputum Conversion Rate at the End of Intensive Tuberculosis Treatment Phase.
    Metanat M; Mashhadi MA; Alavi-Naini R; Rezaie-Kahkhaie L; Sepehri-Rad N; Afshari M
    Prague Med Rep; 2020; 121(1):35-41. PubMed ID: 32191618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study.
    Gatete G; Njunwa KJ; Migambi P; Ntaganira J; Ndagijimana A
    BMC Infect Dis; 2023 Jun; 23(1):408. PubMed ID: 37322426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
    BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A; Jamil M; Rahman MAU; Mustafa T
    BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A; Gelaw B; Wang SH; Tessema B
    PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum completion and conversion rates after intensive phase of tuberculosis treatment: an assessment of the Rwandan control program.
    Kayigamba FR; Bakker MI; Mugisha V; Gasana M; Schim van der Loeff MF
    BMC Res Notes; 2012 Jul; 5():357. PubMed ID: 22800438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of CRP serum levels in pulmonary TB patients with AFB smear-positive sputum before and two months after receiving anti-tuberculosis drug treatment.
    Soedarsono S; Subiantoro MC
    Indian J Tuberc; 2019 Jan; 66(1):134-138. PubMed ID: 30797271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sputum smear conversion and associated factors among smear-positive pulmonary tuberculosis patients in East Gojjam Zone, Northwest Ethiopia: a longitudinal study.
    Asemahagn MA
    BMC Pulm Med; 2021 Apr; 21(1):118. PubMed ID: 33832466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.
    Mily A; Sarker P; Taznin I; Hossain D; Haq MA; Kamal SMM; Agerberth B; Brighenti S; Raqib R
    BMC Infect Dis; 2020 Dec; 20(1):933. PubMed ID: 33287713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to tuberculosis treatment, sputum smear conversion and mortality: a retrospective cohort study in 48 Rwandan clinics.
    Kayigamba FR; Bakker MI; Mugisha V; De Naeyer L; Gasana M; Cobelens F; van der Loeff MS
    PLoS One; 2013; 8(9):e73501. PubMed ID: 24066053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
    J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
    Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
    BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and Risk Factors of Delayed Sputum Smear Conversion in Malaysian Aborigines with Smear-Positive Pulmonary Tuberculosis.
    Ibrahim MN; Nik Husain NR; Daud A; Chinnayah T
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective study.
    Velayutham B; Chadha VK; Singla N; Narang P; Gangadhar Rao V; Nair S; Ramalingam S; Narayanan Sivaramakrishnan G; Joseph B; Selvaraju S; Shanmugam S; Narang R; Pachikkaran P; Bhat J; Ponnuraja C; Bajaj Bhalla B; Shivashankara BA; Sebastian G; Yadav R; Kumar Sharma R; Sarin R; Myneedu VP; Singla R; Khayyam K; Mrithunjayan SK; Jayasankar SP; Sanker P; Viswanathan K; Viswambharan R; Mathuria K; Bhalla M; Singh N; Tumane KB; Dawale A; Tiwari CP; Bansod R; Jayabal L; Murali L; Khaparde SD; Rao R; Jawahar MS; Natrajan M
    PLoS One; 2018; 13(7):e0200150. PubMed ID: 29979738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study.
    Pefura-Yone EW; Kengne AP; Kuaban C
    BMC Infect Dis; 2014 Mar; 14():138. PubMed ID: 24618155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J; Lee BJ; Yoon HI; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.